Rep. Lisa C. McClain Buys Dolby Laboratories (NYSE:DLB) Shares

24 Oct 2025, 08:06 by Jessica Moore · The Cerbat Gem

Representative Lisa C. McClain (R-Michigan) recently bought shares of Dolby Laboratories (NYSE:DLB). In a filing disclosed on October 22nd, the Representative disclosed that they had bought between $1,001 and $15,000 in Dolby Laboratories stock on September 11th. The trade occurred in the Representative’s “CHARLES SCHWAB BROKERAGE ACCOUNT 924” account.

Representative Lisa C. McClain also recently made the following trade(s):

Purchased $1,001 – $15,000 in shares of FMC (NYSE:FMC) on 9/25/2025.
Sold $1,001 – $15,000 in shares of Merit Medical Systems (NASDAQ:MMSI) on 9/25/2025.
Purchased $1,001 – $15,000 in shares of Darden Restaurants (NYSE:DRI) on 9/25/2025.
Purchased $1,001 – $15,000 in shares of ASML (NASDAQ:ASML) on 9/25/2025.
Purchased $1,001 – $15,000 in shares of Kenvue (NYSE:KVUE) on 9/25/2025.
Sold $1,001 – $15,000 in shares of Beacon Financial (NYSE:BBT) on 9/25/2025.
Sold $1,001 – $15,000 in shares of British American Tobacco (NYSE:BTI) on 9/25/2025.
Purchased $1,001 – $15,000 in shares of Rollins (NYSE:ROL) on 9/25/2025.
Purchased $1,001 – $15,000 in shares of SAP (NYSE:SAP) on 9/25/2025.
Purchased $1,001 – $15,000 in shares of MGP Ingredients (NASDAQ:MGPI) on 9/25/2025.

Dolby Laboratories Stock Up 0.6%

DLB opened at $67.64 on Friday. Dolby Laboratories has a 12-month low of $66.96 and a 12-month high of $89.66. The stock has a market cap of $6.48 billion, a price-to-earnings ratio of 24.78 and a beta of 0.92. The business has a 50 day moving average of $71.51 and a 200-day moving average of $73.51.

Dolby Laboratories (NYSE:DLB – Get Free Report) last released its quarterly earnings data on Thursday, July 31st. The electronics maker reported $0.78 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.72 by $0.06. Dolby Laboratories had a return on equity of 11.52% and a net margin of 19.62%.The company had revenue of $315.55 million during the quarter, compared to analysts’ expectations of $305.23 million. During the same period last year, the firm posted $0.71 earnings per share. The business’s revenue was up 9.2% on a year-over-year basis. Dolby Laboratories has set its FY 2025 guidance at 3.880-4.030 EPS. Q4 2025 guidance at 0.610-0.760 EPS. As a group, analysts expect that Dolby Laboratories will post 2.94 earnings per share for the current year.

Dolby Laboratories Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Wednesday, August 20th. Investors of record on Tuesday, August 12th were paid a $0.33 dividend. This represents a $1.32 annualized dividend and a yield of 2.0%. The ex-dividend date was Tuesday, August 12th. Dolby Laboratories’s dividend payout ratio (DPR) is 48.35%.

Insider Buying and Selling at Dolby Laboratories

In related news, CEO Kevin J. Yeaman sold 25,000 shares of the firm’s stock in a transaction that occurred on Tuesday, August 12th. The stock was sold at an average price of $72.31, for a total transaction of $1,807,750.00. Following the completion of the sale, the chief executive officer owned 114,725 shares of the company’s stock, valued at $8,295,764.75. This trade represents a 17.89% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website. Also, SVP Shriram Revankar sold 7,000 shares of Dolby Laboratories stock in a transaction on Friday, August 22nd. The shares were sold at an average price of $74.92, for a total transaction of $524,440.00. Following the completion of the sale, the senior vice president directly owned 70,435 shares of the company’s stock, valued at approximately $5,276,990.20. The trade was a 9.04% decrease in their position. The disclosure for this sale can be found here. Insiders have sold 82,000 shares of company stock valued at $5,845,440 over the last quarter. Company insiders own 38.39% of the company’s stock.

Analyst Ratings Changes

Several equities research analysts have issued reports on DLB shares. Robert W. Baird started coverage on shares of Dolby Laboratories in a research report on Friday, September 5th. They set a “neutral” rating and a $74.00 price objective for the company. Rosenblatt Securities reissued a “buy” rating and set a $95.00 price target on shares of Dolby Laboratories in a report on Friday, August 1st. Barrington Research reissued an “outperform” rating and set a $100.00 price target on shares of Dolby Laboratories in a report on Friday, September 12th. Baird R W raised Dolby Laboratories to a “hold” rating in a report on Friday, September 5th. Finally, Tigress Financial boosted their target price on shares of Dolby Laboratories from $112.00 to $114.00 and gave the company a “buy” rating in a research report on Friday, August 15th. Three equities research analysts have rated the stock with a Buy rating and three have given a Hold rating to the company. According to MarketBeat, the company has a consensus rating of “Moderate Buy” and an average price target of $95.75.

Check Out Our Latest Research Report on Dolby Laboratories

Hedge Funds Weigh In On Dolby Laboratories

Several hedge funds and other institutional investors have recently added to or reduced their stakes in DLB. Bank of New York Mellon Corp raised its stake in Dolby Laboratories by 18.3% in the first quarter. Bank of New York Mellon Corp now owns 5,709,193 shares of the electronics maker’s stock valued at $458,505,000 after purchasing an additional 882,716 shares in the last quarter. Norges Bank acquired a new position in Dolby Laboratories during the second quarter valued at approximately $55,030,000. AQR Capital Management LLC raised its stake in Dolby Laboratories by 51.8% during the second quarter. AQR Capital Management LLC now owns 1,736,260 shares of the electronics maker’s stock worth $128,935,000 after acquiring an additional 592,282 shares in the last quarter. Vanguard Group Inc. increased its position in Dolby Laboratories by 7.1% during the 1st quarter. Vanguard Group Inc. now owns 7,535,722 shares of the electronics maker’s stock worth $605,194,000 after purchasing an additional 502,110 shares in the last quarter. Finally, Jones Financial Companies Lllp increased its position in Dolby Laboratories by 241,160.1% during the 1st quarter. Jones Financial Companies Lllp now owns 429,443 shares of the electronics maker’s stock worth $36,975,000 after purchasing an additional 429,265 shares in the last quarter. 58.56% of the stock is owned by institutional investors and hedge funds.

About Representative McClain

Lisa McClain (Republican Party) is a member of the U.S. House, representing Michigan’s 9th Congressional District. She assumed office on January 3, 2023. Her current term ends on January 3, 2027.

McClain (Republican Party) is running for re-election to the U.S. House to represent Michigan’s 9th Congressional District. She declared candidacy for the 2026 election.

Lisa McClain lives in Romeo, Michigan. McClain earned a bachelor’s degree in business administration from Northwood University. Her career experience includes founding and working as the president of North End Support Team.

About Dolby Laboratories

(Get Free Report)

Dolby Laboratories, Inc creates audio and imaging technologies that transform entertainment at the cinema, DTV transmissions and devices, mobile devices, OTT video and music services, home entertainment devices, and automobiles. The company develops and licenses its audio technologies, such as AAC & HE-AAC, a digital audio codec solution used for a range of media applications; AVC, a digital video codec with high bandwidth efficiency used in various media devices; Dolby AC-4, a digital audio coding technology that delivers new audio experiences to a range of playback devices; and Dolby Atmos technology for cinema and various media devices.